| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 9th September 2020 | Ii Robert C. Goeltz | 5,000 | Open or private purchase | $21.57 | $107,848.50 |
| 10th August 2020 | Terry J Rosen | 32,050 | Open or private purchase | $23.38 | $749,402.72 |
| 7th August 2020 | Terry J Rosen | 11,655 | Open or private purchase | $21.44 | $249,911.17 |
| 31st July 2020 | William Grossman | 100 | Open or private purchase | $19.68 | $1,967.56 |
| 31st July 2020 | William Grossman | 100 | Open or private purchase | $19.77 | $1,977.00 |
| 22nd June 2020 | Ii Robert C. Goeltz | 2,483 | Payment by withholding | $9.67 | $24,010.61 |
| 12th June 2020 | Jennifer Jarrett | 2,446 | Grant/award etc. | $0.00 | |
| 11th June 2020 | Kathryn E Falberg | 5,670 | Grant/award etc. | $0.00 | |
| 5th June 2020 | Yasunori Kaneko | 35,000 | Exercise of derivative | $7.99 | $279,650.00 |
| 4th June 2020 | Yasunori Kaneko | 3,000 | Grant/award etc. | $0.00 |
Arcus Biosciences
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Ticker: RCUS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1724521
Employees: 139
Exchange: New York Stock Exchange
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Japanese fashionista aiming to put Filipino kids on runway to success
22nd September 2020
BlackRock, JPMorgan climate votes at odds as new rules loom
22nd September 2020
Arcus Biosciences (RCUS) Investor Presentation - Slideshow
18th September 2020
